Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Neurosciences (18)
- Medical Specialties (12)
- Life Sciences (11)
- Neurology (11)
- Neuroscience and Neurobiology (9)
-
- Diseases (6)
- Medical Cell Biology (6)
- Social and Behavioral Sciences (6)
- Anatomy (4)
- Psychology (4)
- Genetic Processes (3)
- Medical Anatomy (3)
- Medical Genetics (3)
- Molecular and Cellular Neuroscience (3)
- Musculoskeletal, Neural, and Ocular Physiology (3)
- Nervous System (3)
- Nervous System Diseases (3)
- Behavioral Neurobiology (2)
- Biochemical Phenomena, Metabolism, and Nutrition (2)
- Biological Phenomena, Cell Phenomena, and Immunity (2)
- Chemical and Pharmacologic Phenomena (2)
- Chemicals and Drugs (2)
- Family, Life Course, and Society (2)
- Geriatrics (2)
- Medical Biochemistry (2)
- Medical Immunology (2)
- Medical Molecular Biology (2)
- Institution
-
- University of Kentucky (6)
- Dartmouth College (4)
- University of Nevada, Las Vegas (3)
- Edith Cowan University (2)
- Liberty University (2)
-
- Marquette University (2)
- Thomas Jefferson University (2)
- University of New England (2)
- Virginia Commonwealth University (2)
- Wright State University (2)
- Chapman University (1)
- Himmelfarb Health Sciences Library, The George Washington University (1)
- LSU New Orleans (1)
- Philadelphia College of Osteopathic Medicine (1)
- The University of Akron (1)
- University of Nebraska Medical Center (1)
- Western Michigan University (1)
- Keyword
-
- Animals (3)
- Animal (2)
- Cell-line derived (2)
- Convection-enhanced infusion (2)
- Gene expression (2)
-
- Glial (2)
- Neurotrophic factor (2)
- Parkinson's Disease (2)
- Putamen (2)
- Schizophrenia (2)
- Stress (2)
- Therapeutics (2)
- Transgenic (2)
- 129 Strain (1)
- 4-hydroxynonenal (1)
- AIS (1)
- APOE4 (1)
- Acidic (1)
- Acrolein (1)
- Addiction (1)
- Aggregate (1)
- Alzheimer's Disease (1)
- Alzheimer's disease (1)
- Alzheimers disease (1)
- Alzheimer’s disease (1)
- Amino Acid Transport Systems (1)
- Amino Acid Transport Systems, Acidic (1)
- Amla (1)
- Arousal (1)
- Auditory Learning (1)
- Publication
-
- Dartmouth Scholarship (4)
- UNLV Theses, Dissertations, Professional Papers, and Capstones (3)
- Department of Neuroscience Faculty Papers (2)
- Dissertations (1934 -) (2)
- Neuroscience Faculty Patents (2)
-
- Neuroscience, Cell Biology & Physiology Faculty Publications (2)
- Sanders-Brown Center on Aging Faculty Publications (2)
- AUCTUS: The Journal of Undergraduate Research and Creative Scholarship (1)
- Biology Student Publications (1)
- Brain Blast (1)
- ECU Posters (1)
- LSU New Orleans Theses and Dissertations (1)
- Masters Theses (1)
- Neurology Faculty Publications (1)
- PCOM Biomedical Studies Student Scholarship (1)
- Physical Therapy Faculty Articles and Research (1)
- Research outputs 2014 to 2021 (1)
- Senior Honors Theses (1)
- The Kabod (1)
- Theses & Dissertations (1)
- Theses and Dissertations (1)
- Theses and Dissertations--Neuroscience (1)
- Theses and Dissertations--Physiology (1)
- Williams Honors College, Honors Research Projects (1)
- Publication Type
Articles 31 - 34 of 34
Full-Text Articles in Medical Neurobiology
Morphometric Analysis Of Left & Right Tonsils In Adult Symptomatic Type 1 Chiari Patients And Healthy Controls, Louis J. Konstan
Morphometric Analysis Of Left & Right Tonsils In Adult Symptomatic Type 1 Chiari Patients And Healthy Controls, Louis J. Konstan
Williams Honors College, Honors Research Projects
Historically, CMI has been radiographically defined by cerebellar tonsillar descent below the foramen magnum (FM) more than 5 mm (2). This measurement is typically made with a single sagittal plane T1-or T2-weighted MR image. Studies have obtained additional morphometric measurements to help diagnose CMI, and establish normal values (3,4). These studies were somewhat These studies were somewhat successful in differentiating CMI patients from healthy subjects. However, results from these studies have shown that the standard TD measurement does not necessarily correlate with neurological symptom severity as patients with CMI-like symptoms have been found with a TD of less than 5 …
Amla Enhances Autophagy And Modulates Beta Amyloid Metabolism In An In Vitro Model Of Alzheimer’S Disease, Elham Teimouri, Prashant Bharadwaj, Stephanie R. Rainey-Smith, Paul Fraser, Giuseppe Verdile, Ralph N. Martins
Amla Enhances Autophagy And Modulates Beta Amyloid Metabolism In An In Vitro Model Of Alzheimer’S Disease, Elham Teimouri, Prashant Bharadwaj, Stephanie R. Rainey-Smith, Paul Fraser, Giuseppe Verdile, Ralph N. Martins
ECU Posters
Alzheimer’s disease (AD) is a progressive, fatal neurodegenerative disease characterized by extensive neuronal loss associated with increased accumulation of the beta amyloid (Aβ) protein. Reducing production, preventing aggregation and improving clearance of Aβare areas of active research in the development of therapeutic agents to ameliorate neurodegeneration in AD. The Indian plant amla (Emblicaofficinalis), commonly known as Indian gooseberry, has widely been utilized in traditional Ayurvedic medicine preparations in the treatment of a variety of disease conditions including cardiovascular disease and diabetes: accumulating evidence also suggests that amla may be beneficial in AD. Amla exhibits antioxidant, anti-inflammatory, and anti-apoptotic mechanisms and …
Axon Initial Segment Stability In Multiple Sclerosis, Suneel K. Thummala
Axon Initial Segment Stability In Multiple Sclerosis, Suneel K. Thummala
Theses and Dissertations
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by inflammation and demyelination. In addition to these hallmark features, MS also presents with axonal pathology, which is likely responsible for the signs and symptoms of the disease. Although prominent in MS, axonal pathology is frequently considered a consequence of demyelination and not a primary event. This conclusion is consistent with demyelination inducing the loss of specific axonal domains, known as the nodes of Ranvier that are responsible for the propagation of action potentials along the axon. In contrast, we propose that axonal pathology associated with MS …
Neural Function, Injury, And Stroke Subtype Predict Treatment Gains After Stroke, Erin Burke Quinlan, Lucy Dodakian, Jill See, Alison Mackenzie, Vu Le, Mike Wojnowicz, Babak Shahbaba, Steven C. Cramer
Neural Function, Injury, And Stroke Subtype Predict Treatment Gains After Stroke, Erin Burke Quinlan, Lucy Dodakian, Jill See, Alison Mackenzie, Vu Le, Mike Wojnowicz, Babak Shahbaba, Steven C. Cramer
Physical Therapy Faculty Articles and Research
Objective
This study was undertaken to better understand the high variability in response seen when treating human subjects with restorative therapies poststroke. Preclinical studies suggest that neural function, neural injury, and clinical status each influence treatment gains; therefore, the current study hypothesized that a multivariate approach incorporating these 3 measures would have the greatest predictive value.
Methods
Patients 3 to 6 months poststroke underwent a battery of assessments before receiving 3 weeks of standardized upper extremity robotic therapy. Candidate predictors included measures of brain injury (including to gray and white matter), neural function (cortical function and cortical connectivity), and clinical …